Immune dysregulation is thought to be a contributing factor to the development of microscopic colitis (MC), which encompasses lymphocytic and collagenous colitis. MC pattern has been observed in colitis resulting from immunotherapy, newer agents that work on the immune system to augment its response against tumor cells. We describe a case of collagenous colitis that developed after the use of anti-PD1 antibody.